Medical Cannabis
Majority of UK Medical Cannabis Flower Now at 25% THC or Above, New Data Shows
New NHS data reveals a significant shift in UK medical cannabis prescribing, with 85% of flower items now exceeding 22% THC potency.
Medical Cannabis
Prescription cannabis, NHS developments, and patient access in the UK.
Medical Cannabis
First Patient Dosed in Ananda Pharma CBD Trial for Chemotherapy Nerve Pain
Ananda Pharma has dosed the first patient in its Phase 2 ACTiON trial testing MRX1, a proprietary CBD medicine, for chemotherapy-induced peripheral neuropathy.
Medical Cannabis
Nine in Ten Late-Stage Dementia Patients Improved on THC/CBD in Landmark LiBBY Trial
A US Phase 2 study presented in London found a purified THC and CBD oil sharply reduced agitation in hospice-eligible dementia patients — but researchers warn it is not the same as shop-bought cannabis products.
Medical Cannabis
Rua Bioscience Signs NZ$10m UK Medical Cannabis Flower Deal With Major Clinic Partner
New Zealand producer Rua Bioscience has agreed to supply medical cannabis flower to one of the UK's largest private clinic and distribution groups, in a two-year deal worth more than NZ$10 million.
Medical Cannabis
Whole Cannabis Extract May Beat THC Alone for Metabolic Health, Mouse Study Suggests
Research in The Journal of Physiology finds obese mice lost weight on both THC and whole-plant cannabis extract — but only the full extract improved blood sugar control, hinting that non-THC compounds may matter for metabolism.
Medical Cannabis
Cannabis Use Not Linked to Dementia Risk in Older Adults, Major BMJ Study Finds
Research in BMJ Mental Health using UK Biobank and US veteran data finds cannabis use in older adults is not associated with faster cognitive decline or higher dementia risk — though scientists warn heavy, long-term use remains poorly understood.
Medical Cannabis
Releaf Registers as GP Practice to Support Patients Who Do Not Qualify for Cannabis
UK clinic Releaf has registered as a fully integrated GP practice, allowing it to prescribe standard BNF medicines for the significant share of patients who complete triage but are not eligible for medical cannabis.
Medical Cannabis
Medical Cannabis Access Linked to Fewer Health-Related Sick Days, US Study Finds
Research published in the Journal of Workplace Behavioral Health links medical cannabis laws to a 6.9% drop in health-related absenteeism, with manual workers seeing the sharpest reductions.